Search results
As the US moves to reclassify marijuana as a less dangerous drug, could more states legalize it?
KSAN - KLST San Angelo· 1 day agoAs the U.S. government moves toward reclassifying marijuana as a less dangerous drug, there may be...
Weight loss drug shortage: Zepbound and Wegovy in short supply, says FDA
BenefitsPRO· 3 days agoThe FDA anticipates limited availability through the end of the second financial quarter, or at...
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
Motley Fool via Yahoo Finance· 2 hours agoIf not for its rapidly rising share price, Eli Lilly's dividend yield would be much higher than it...
These Are the Drugs America Is Running Short On
247wallst.com· 6 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
... Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update -...
Benzinga· 2 hours agoCathie Wood-run Ark Invest on Friday picked up shares of a biopharma company after it revealed...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 hours agoAbstracts being presented at the American Urological Association's Annual Meeting discuss the Mark Cuban Cost Plus Drug Company and treatment of urogynecologic ...
Within a few years, generative AI will be designing new drugs all on its own
NBC Miami· 8 hours agoWithin a few years, experts at Lilly and Nvidia say AI will not only think up new drugs, but ones...
Reclassifying Marijuana Could Unlock Billions in Tax Savings for Cannabis Companies
The Wall Street Journal· 8 hours agoBUSINESS Many U.S. cannabis businesses could become profitable for the first time if the Biden...
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
FOX 59 Indianapolis· 6 days agoSACRAMENTO, Calif. (AP) — California is partnering with a New Jersey-based pharmaceutical company to...
2 Magnificent Dividend Stocks to Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 hours agoMoreover, the need for innovative therapies isn't going to subside anytime soon. In fact, it will...